Valuation: RAMM Pharma Corp.

Market Cap 1.19M 844K 741K 700K 638K 80.94M 1.2M 8.37M 3.24M 41.35M 3.17M 3.1M 133M P/E 2024
-0.07x
P/E 2025 -0.2x
Enterprise Value 470K 333K 292K 276K 251K 31.89M 474K 3.3M 1.28M 16.29M 1.25M 1.22M 52.36M EV / Sales 2024
0.13x
EV / Sales 2025 0.32x
Free-Float
68.57%
Yield 2024 *
-
Yield 2025 -
1 day+100.00%
Current month+100.00%
1 month+100.00%
3 months-33.33%
6 months-33.33%
Current year-83.33%
1 month 0
Extreme 0.005
0.01
Current year 0
Extreme 0.005
0.05
1 year 0
Extreme 0.005
0.25
3 years 0
Extreme 0
0.25
5 years 0
Extreme 0
0.6
10 years 0
Extreme 0
1.19
Manager TitleAgeSince
Chief Executive Officer - 2019-09-30
Director of Finance/CFO - 2022-12-08
Director TitleAgeSince
Director/Board Member - 2019-09-30
Director/Board Member 82 2019-09-30
Director/Board Member 66 2019-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/25 Sell

Chief Executive Officer

4,667,000 3.9091%
3/21/25 Buy

Chief Executive Officer

200,000 0.1675%
3/21/25 Buy

Chief Executive Officer

100,000 0.0838%
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%0.00%0.00%-90.00% 844K
+0.13%+2.65%+63.34%+115.27% 1,055B
+0.20%+0.46%+50.92%+72.63% 654B
-0.29%+0.14%+19.82%+72.62% 467B
-0.85%+0.98%+42.13%+42.98% 348B
+0.71%+4.08%+21.75%+29.57% 275B
+1.23%+0.42%+14.11%+12.90% 258B
+2.11%+7.51%+51.88%+54.14% 224B
+0.83%+0.55%+34.64%+99.77% 187B
0.00%-10.14%-27.40%-60.93% 171B
Average +10.41%+0.67%+27.12%+34.90% 363.83B
Weighted average by Cap. +0.27%+1.32%+40.43%+68.66%

Financials

2024 2025
Net sales 4.34M 3.07M 2.69M 2.55M 2.32M 294M 4.37M 30.46M 11.8M 150M 11.53M 11.28M 483M 3.36M 2.38M 2.09M 1.97M 1.8M 228M 3.38M 23.57M 9.13M 116M 8.92M 8.73M 374M
Net income -16.5M -11.67M -10.24M -9.67M -8.82M -1.12B -16.62M -116M -44.83M -572M -43.82M -42.88M -1.84B -8.91M -6.3M -5.53M -5.22M -4.76M -604M -8.97M -62.5M -24.21M -309M -23.66M -23.15M -992M
Net Debt -626K -443K -388K -367K -334K -42.42M -630K -4.39M -1.7M -21.67M -1.66M -1.63M -69.65M -723K -512K -449K -424K -386K -49.05M -729K -5.08M -1.97M -25.06M -1.92M -1.88M -80.53M
Logo RAMM Pharma Corp.
RAMM Pharma Corp. is a Canada-based company that is primarily engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. It has multiple approved and registered products that have been authorized for sale, as well as other products in various stages of development. The Company also operates GMP certified cannabis formulation facilities in Uruguay and Poland to ensure their products are compliant with the standard and address international markets. The Company owns and operates a medical services business in Uruguay and a cosmetic and nutraceutical business in the European Union. The Company's brands include Medic Plast, Nettalife, Canapar, and Marishanti. Its subsidiaries include Medic Plast S.A., Yurelan S.A., RAMM Pharma Holdings Corp., Canapar Corp, and Hempoland S.p.a Z.o.o.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. RAMM Stock